Pediatric Hodgkin lymphoma– biomarkers, drugs, and clinical trials for translational science and medicine

Hodgkin lymphoma (HL) is a lymphoid malignancy that is typically derived from germinal-center B cells. EBV infection, mutations in NF-κB pathway genes, and genetic susceptibility are known risk factors for developing HL. CD30 and NF-κB have been identified as potential biomarkers in pediatric HL pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagpal, Poonam, Akl, Mohamed R., Ayoub, Nehad M., Tomiyama, Tatsunari, Cousins, Tasheka, Tai, Betty, Carroll, Nicole, Nyrenda, Themba, Bhattacharyya, Pritish, Harris, Michael B., Goy, Andre, Pecora, Andrew, Suh, K. Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341896/
https://www.ncbi.nlm.nih.gov/pubmed/27563824
http://dx.doi.org/10.18632/oncotarget.11509

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341896/
https://www.ncbi.nlm.nih.gov/pubmed/27563824
http://dx.doi.org/10.18632/oncotarget.11509

Ejemplares similares